Inferior Vena Cava Collapsibility and Distensibility Assessment in Critical Care.

NCT ID: NCT06516692

Last Updated: 2024-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will help in determining the impact of assessment of Inferior Vena Cava Collapsibility and Distensibility Index (IVC CI and DI) through Point Of Care Ultra Sound (POCUS), for the fluid management of critically ill patients. This would help in better management of such patients in resource limited countries, where costly equipment for cardiac output monitoring and fluid management are frequently not available.

Moreover this study will help in development of future guidelines for fluid resuscitation in critically ill patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current study is a randomized clinical trial with the aim to explore comparative outcome between IVC CI and DI versus clinical parameters guided fluid management groups in patients of sepsis, Acute renal failure, Acute gastroenteritis and Diabetic ketoacidosis in terms of,

1. Within 24 hours 7 day and 28 day mortality
2. Change in Sequential Organ failure Assessment (ΔSOFA) score from baseline to 24 hours after fluid management.
3. Cumulative fluid balance at 6 hours of fluid management
4. Days on mechanical ventilation
5. Days in Intensive Care Unit (ICU)
6. Change in lactic acid levels in sepsis sub group
7. Change in Blood sugar Random (BSR) in Diabetic ketoacidosis (DKA) sub group
8. Change in Power of Hydrogen (PH) in septic and diabetic ketoacidosis sub group of participant

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis Acute Renal Failure Acute Gastroenteritis Diabetic Ketoacidosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Inferior Vena Cava Collapsibility and Distensibility index Fluid management Resuscitation Clinical parameters Sepsis Acute gastroenteritis Acute Renal failure Diabetic ketoacidosis Mortality Cumulative fluid balance Lactic acid Sequential Organ Failure Assessment score Mechanical Ventilation Critical Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinical Parameters guided assessment arm

Participants recruited to this arm will be assessed for their hydration status and further fluid management as per usual care of assessment through

* Capillary refill time
* Presence/absence of pulmonary rales.
* Jugular venous pressure assessment by clinical methods
* Presence / absence of pedal edema

Group Type NO_INTERVENTION

No interventions assigned to this group

Inferior Vena Cava Collapsibility and Distensibility guided assessment arm

Participants recruited in this arm will be assessed through measurement of inferior vena cava diameter via subcostal window within 3 cm of its opening to right atrium through point of care ultrasound using a curvilinear or phased array probe.

For spontaneously breathing patients Inferior Vena Cava Collapsibility Index (IVC CI) will be calculated as:

\[(IVC diameter max-IVC diameter min)/IVC diameter max\]×100%

* IVC CI \> 50% = overt hypovolemia
* IVC CI \< 20% = no overt hypovolemia
* IVC CI of 20% to 50% will be goal

For mechanically ventilated patients Inferior Vena Cava Distensibility Index (IVC DI) will be calculated as:

\[(IVC diameter max-IVC diameter min)/IVC diameter min\]×100% IVC distensibility\>18% = hypovolemia IVC distensibility\<18% = no hypovolemia

Group Type EXPERIMENTAL

Inferior Vena Cava Collapsibility/distensibility Index (IVC CI/DI) assessment

Intervention Type DIAGNOSTIC_TEST

Assessment of hydration status in critically ill patient recruited to this arm will be intervened through an ultrasound guided calculation of collapsibility and distensibility index of Inferior Vena Cava. This method of intervention will be continued and repeated as needed throughout the stay of the participant in intensive care unit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inferior Vena Cava Collapsibility/distensibility Index (IVC CI/DI) assessment

Assessment of hydration status in critically ill patient recruited to this arm will be intervened through an ultrasound guided calculation of collapsibility and distensibility index of Inferior Vena Cava. This method of intervention will be continued and repeated as needed throughout the stay of the participant in intensive care unit.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted in critical care with systolic Blood Pressure \< 90 mmHg with any of the diagnosis as per operational definition:
* Sepsis
* Diabetic ketoacidosis
* Acute kidney injury
* Acute gastroenteritis

Exclusion Criteria

* Known case of right heart disease
* Known case of congestive cardiac failure
* Presence of marked ascites
* IVC could not be identified or diameter could not be measured
* Pregnant females
* Body Mass Index (BMI) \>30 Kg/meter2
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jinnah Postgraduate Medical Centre

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shamim Kausar, EDIC,FCPS

Role: PRINCIPAL_INVESTIGATOR

Jinnah Post Graduate and Medical Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jinnah Post graduate Medical Centre

Karachi, Sindh, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

References

Explore related publications, articles, or registry entries linked to this study.

Kashani K, Omer T, Shaw AD. The Intensivist's Perspective of Shock, Volume Management, and Hemodynamic Monitoring. Clin J Am Soc Nephrol. 2022 May;17(5):706-716. doi: 10.2215/CJN.14191021. Epub 2022 Apr 4.

Reference Type BACKGROUND
PMID: 35379765 (View on PubMed)

Basmaji J, Arntfield R, Desai K, Lau VI, Lewis K, Rochwerg B, Fiorini K, Honarmand K, Slessarev M, Leligdowicz A, Park B, Prager R, Wong MYS, Jones PM, Ball IM, Orozco N, Meade M, Thabane L, Guyatt G. The Impact of Point-of-Care Ultrasound-Guided Resuscitation on Clinical Outcomes in Patients With Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2024 Nov 1;52(11):1661-1673. doi: 10.1097/CCM.0000000000006399. Epub 2024 Sep 18.

Reference Type BACKGROUND
PMID: 39298556 (View on PubMed)

Musikatavorn K, Plitawanon P, Lumlertgul S, Narajeenron K, Rojanasarntikul D, Tarapan T, Saoraya J. Randomized Controlled Trial of Ultrasound-guided Fluid Resuscitation of Sepsis-Induced Hypoperfusion and Septic Shock. West J Emerg Med. 2021 Feb 10;22(2):369-378. doi: 10.5811/westjem.2020.11.48571.

Reference Type BACKGROUND
PMID: 33856325 (View on PubMed)

Spiliotaki E, Saranteas T, Moschovaki N, Panagouli K, Pistioli E, Kitsinelis V, Briasoulis P, Papadimos T. Inferior vena cava ultrasonography in the assessment of intravascular volume status and fluid responsiveness in the emergency department and intensive care unit: A critical analysis review. J Clin Ultrasound. 2022 Jun;50(5):733-744. doi: 10.1002/jcu.23194. Epub 2022 Mar 18.

Reference Type BACKGROUND
PMID: 35302241 (View on PubMed)

Kaptein EM, Kaptein MJ. Inferior vena cava ultrasound and other techniques for assessment of intravascular and extravascular volume: an update. Clin Kidney J. 2023 Jun 29;16(11):1861-1877. doi: 10.1093/ckj/sfad156. eCollection 2023 Nov.

Reference Type BACKGROUND
PMID: 37915939 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://pubmed.ncbi.nlm.nih.gov/35379765/

The Intensivist's Perspective of Shock, Volume Management, and Hemodynamic Monitoring

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NO.F.2-81/2023-GENL/64/JPMC

Identifier Type: -

Identifier Source: org_study_id